Cited by 35RNA and protein synthesis mechanismsBacterial Genetics and BiotechnologyMicrobial Natural Products and Biosynthesis

The DOI matches its Crossref record.

Comparative Analysis of the Effect of Aminoglycosides on Bacterial Protein Synthesis in vitro

Open access
ZIERHUT, Gertraud, PIEPERSBERG, Wolfgang, BÖCK, August·1979·European Journal of Biochemistry

Abstract

The effect of aminoglycoside antibiotics on bacterial protein synthesis in an initiating system was investigated. Three classes of compounds can be differentiated as to their response. (1) Antibiotics (streptomycin, bluensomycin and hygromycin B) which inhibit polypeptide synthesis in a monophasic way indicating a single major inhibitory site. Polypeptides made under partially inhibitory conditions possess the same size as those produced without the drug. (2) Compounds containing 2‐deoxystreptamine in a diglycosylated form (gentamicins B, C 1, C 1a and C 2; sisomicin; kanamycin; neomycin; tobramycin; lividomycin A and paromomycin) inhibit protein synthesis in the triphasic way recently reported for gentamicin C complex which indicates multiple interactions of these antibiotics with the ribosome. These compounds also share the property of promoting the synthesis of longer than normal peptides due to termination errors. (3) The disaccharidic sisomicin and lividomycin cleavage products, garamine and lividamine respectively, give a biphasic response, namely stimulation of the rate of polypeptide synthesis at low concentration and inhibition at increasing concentrations. Aminoglycosides of class 2 (when present at second‐phase concentration) can revert the inhibition of protein synthesis caused by each of the class 1 compounds. Concomitantly, ‘read‐through’ products are accumulated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1432-1033.1979.tb13219.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 24

  1. 10.1016/S0021-9258(18)93308-9 · DOI
  2. 10.1111/j.1432-1033.1978.tb12347.x · DOI
  3. 10.1016/0006-291X(78)91493-6 · DOI
  4. 10.1021/bi00568a029 · DOI
  5. 10.1021/bi00568a028 · DOI
  6. 10.1016/0006-291X(78)90178-X · DOI
  7. 10.1007/BF00455118 · DOI
  8. 10.1016/0022-2836(72)90108-8 · DOI
  9. 10.1016/S0022-2836(66)80263-2 · DOI
  10. 10.1016/0022-2836(72)90329-4 · DOI
  11. 10.1007/BF00274011 · DOI
  12. 10.1073/pnas.61.4.1279 · DOI
  13. 10.1128/AAC.2.4.294 · DOI
  14. 10.1016/0022-2836(73)90248-9 · DOI
  15. 10.1111/j.1432-1033.1976.tb10587.x · DOI
  16. 10.1073/pnas.75.11.5534 · DOI
  17. Weber K., 1975, RNA Phages, 51
  18. 10.1073/pnas.51.5.883 · DOI
  19. Gorini L., 1974, Ribosomes, 791
  20. 10.1073/pnas.61.2.768 · DOI
  21. 10.1073/pnas.67.3.1148 · DOI
  22. 10.7164/antibiotics.25.212 · DOI
  23. Davies J., 1965, Mol. Pharmacol., 1, 93
  24. Gale E. F., 1972, The Molecular Basis of Antibiotic Action, 278

Cited by

Sorted by citations

Metadata

Authors
ZIERHUT, G., PIEPERSBERG, W., & BÖCK, A.
Affiliations
University of Regensburg (DE)
Venue
European Journal of Biochemistry
Publisher
Wiley
Published
1979-08
Volume
98
Issue
2
Pages
577-583
ISSN
  • 0014-2956 (ISSN-L)
  • 1432-1033
OpenAlex
W2074829556
Cited by
35
References
0
Citations by year
2025: 1 · 2024: 1 · 2021: 1 · 2019: 1
FWCI
0.69
Type
journal article
Language
en
Open access
Locations
  • European Journal of Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
aminoglycosides, bacterial protein synthesis, ribosome, streptomycin, hygromycin B, gentamicin, sisomicin, kanamycin, neomycin, tobramycin, paromomycin, 2-deoxystreptamine, readthrough, antibiotic binding sites
MeSH terms
Aminoglycosides, Bacterial Proteins, Drug Resistance, Microbial, Escherichia coli, Gentamicins, Kinetics, Ribosomes, Streptomycin, Structure-Activity Relationship, Protein Biosynthesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review